Figure 2
From: SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
Validation of the 4-GES in gene expression data set GSE6891, containing cytogenetically heterogeneous AML patients. (A) Cohort 1 (N = 222), (B) cohort 2 (N = 185). Kaplan Meier curves for overall survival of 4-GESlow (blue) and 4-GEShigh (red) patients are shown. Statistical significance was calculated using the log rank test and p-values were adjusted for multiple testing according to Altman et al.58.
